Anti-CD22 (Epratuzumab)-CL2E-SN-38 ADC
This ADC product is comprised of an a Epratuzumab conjugated via a CL2E linker to a SN-38. The SN-38 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. The SN-38 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, SN-38 binds to DNA, causes DNA damage.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6146246-01 0.1 mL
Calnexin (CANX, CNX, FLJ26570, Histocompatibility Complex Class I Antigen Binding Protein p88, IP90, P90) (FITC)
Sign In for Pricing
View Details 
MBS6146246-02 5x 0.1 mL
Calnexin (CANX, CNX, FLJ26570, Histocompatibility Complex Class I Antigen Binding Protein p88, IP90, P90) (FITC)
Sign In for Pricing
View Details GTR15352540 1 Vial
Lentiviral human TNR shRNA (UAS) - Lentiviral human TNR shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
MBS6200183-01 0.1 mL
CLIP3 (CLIPR59, CAP-Gly Domain-containing Linker Protein 3, Cytoplasmic Linker Protein 170-related 59kD Protein) (MaxLight 490)
Sign In for Pricing
View Details